Opinion
Video
Author(s):
Dr Amir H. Lebastchi delves into the latest advancements and evolving tactics in the field of prostate cancer biopsy and diagnostic procedures.
FDA Updates in Urology: January 2025
Dr. Murphy on increasing diversity in cancer clinical trials
Urologic Cancer Facts and Updates for World Cancer Day 2025
Dr. Schwen on focal therapies for prostate cancer
Acute toxicity after prostate cancer radiotherapy increases odds of late toxicity
MPS2 test validated for detection of high-grade prostate cancer in non-DRE urine